Several studies showed that PSA was a sensitive marker for detecting residual disease and recurrence after treatment of prostate cancer during follow-up as we still consider an undetectable level of PSA after radical prostatectomy as indicating the absence of postoperative recurrence [20–22]. This evidence concerns the gene KLK3 and prostate cancer.